[A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer].
Jiang ZF, Xu FR, Fan J, Li BJ, Gao JN, Hu JW, Wang XJ, Zhang YQ, Wang JH, Li F, Liu Q, Liu YH, Wang S, Wang YS, Ouyang QC, Hu B, Sun GP, Zhang Y, Zang AM, Fan PZ, Wu CP, Liu J, Zhang HW, Wang W, Hu XC, Tang LL, Zhang J, Bao YY, Geng CZ, Sun Q, Zhang F, Yin YM, Jiang HC, An YH.
Jiang ZF, et al. Among authors: an yh.
Zhonghua Yi Xue Za Zhi. 2018 Apr 24;98(16):1231-1235. doi: 10.3760/cma.j.issn.0376-2491.2018.16.009.
Zhonghua Yi Xue Za Zhi. 2018.
PMID: 29747310
Clinical Trial.
Chinese.